Alejandra Carvajal

2021

In 2021, Alejandra Carvajal earned a total compensation of $2.2M as Senior Vice President, Chief Legal Officer at Mersana Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$107,712
Option Awards$1,346,209
Salary$274,359
Stock Awards$449,970
Total$2,178,250

Carvajal received $1.3M in option awards, accounting for 62% of the total pay in 2021.

Carvajal also received $107.7K in non-equity incentive plan, $274.4K in salary and $450K in stock awards.

Rankings

In 2021, Alejandra Carvajal's compensation ranked 5,728th out of 12,415 executives tracked by ExecPay. In other words, Carvajal earned more than 53.9% of executives.

ClassificationRankingPercentile
All
5,728
out of 12,415
54th
Division
Manufacturing
2,428
out of 5,505
56th
Major group
Chemicals And Allied Products
1,052
out of 2,375
56th
Industry group
Drugs
939
out of 2,096
55th
Industry
Pharmaceutical Preparations
676
out of 1,546
56th

Pay ratio

Alejandra Carvajal's Pay$2,178,250
Median Employee's Pay$302,642
Pay Ratio

7

to 1

In 2021, the annual total compensation of Alejandra Carvajal was $2,178,250.

The annual total compensation of the median employee at Mersana Therapeutics was $302,642.

The ratio of Alejandra Carvajal's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 29, 2022.

Carvajal's colleagues

We found six more compensation records of executives who worked with Alejandra Carvajal at Mersana Therapeutics in 2021.

2021

Anna Protopapas

Mersana Therapeutics

Chief Executive Officer

2021

Timothy Lowinger

Mersana Therapeutics

Senior Vice President, Chief Science and Technology Officer

2021

Brian DeSchuytner

Mersana Therapeutics

Chief Financial Officer

2021

Michael Kaufman

Mersana Therapeutics

Former Chief Manufacturing Officer

2021

Tushar Misra

Mersana Therapeutics

Senior Vice President, Chief Manufacturing Officer

2021

Arvin Yang

Mersana Therapeutics

Chief Medical Officer

News

In-depth

You may also like